• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Recombinant human GM-CSF in small cell lung cancer: a phase I/II study.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Anderson, Heather
    Gurney, H
    Thatcher, Nick
    Swindell, Ric
    Scarffe, J Howard
    Weiner, J
    Affiliation
    CRC Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom.
    Issue Date
    1991
    
    Metadata
    Show full item record
    Abstract
    Seventeen patients with small cell lung cancer were entered into a dose ranging phase I-II study using rhGM-CSF (Glaxo). In the phase I study patients received 50, 150, 300 or 500 micrograms/m2 GM-CSF for 10 days by daily subcutaneous injection. Full blood counts were performed thrice weekly. After 4 days off all therapy patients then received chemotherapy with doxorubicin 50 mg/m2 i.v. bolus, day 1, ifosfamide 5 g/m2 with mesna 5 g/m2 over 24 h by continuous infusion followed by mesna 3 g/m2, and etoposide 120 mg/m2 i.v. on days 1-3. A total of six courses of chemotherapy were given. In the phase II study patients received the same dose of GM-CSF as in the phase I. GM-CSF was given 24 h after the last dose of chemotherapy for 14 days. Full blood counts were checked thrice weekly and the incidence of infections noted. Patients were randomised to receive GM-CSF with either odd or even courses of chemotherapy. The leucocyte count rose from a mean of 8.7 to 21.6 x 10(9)/l at the 50 micrograms/m2 GM-CSF dosage and from 11.4 to 39.4 x 10(9)/l at the 500 micrograms/m2 dosage during the phase I study. Phase I toxicity was: bone pain in 65% of patients, rash in 47%, fever in 24%, lethargy in 12% and diarrhoea in 12%. In the phase II study the duration of neutropenia was less during the chemotherapy courses with GM-CSF (p = 0.04) but the number of infections was similar.(ABSTRACT TRUNCATED AT 250 WORDS)
    Citation
    Recombinant human GM-CSF in small cell lung cancer: a phase I/II study. 1991, 121:155-61 Recent Results Cancer Res.
    Journal
    Recent Results in Cancer Research
    URI
    http://hdl.handle.net/10541/107853
    PubMed ID
    1650015
    Type
    Article
    Language
    en
    ISSN
    0080-0015
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Effect of rhGM-CSF on haematopoietic reconstitution after chemotherapy in small-cell lung cancer.
    • Authors: Havemann K, Klausmann M, Wolf M, Fischer JR, Drings P, Oster W
    • Issue date: 1991
    • Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor.
    • Authors: Gurney H, Anderson H, Radford J, Potter MR, Swindell R, Steward W, Kamthan A, Chang J, Weiner J, Thatcher N
    • Issue date: 1992
    • Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma.
    • Authors: Hamm J, Schiller JH, Cuffie C, Oken M, Fisher RI, Shepherd F, Kaiser G
    • Issue date: 1994 Dec
    • Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF.
    • Authors: Ford PA, Arbuck SG, Minniti C, Miller LL, DeMaria D, O'Dwyer PJ
    • Issue date: 1996 Apr
    • Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin.
    • Authors: Brugger W, Frisch J, Schulz G, Pressler K, Mertelsmann R, Kanz L
    • Issue date: 1992 Sep
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.